Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity.

Khan SA, Nelson MS, Pan C, Gaffney PM, Gupta P.

Am J Physiol Cell Physiol. 2008 Jun;294(6):C1387-97. doi: 10.1152/ajpcell.00346.2007. Epub 2008 Apr 2.

2.

The Bone Morphogenetic Proteins and Their Antagonists.

Mulloy B, Rider CC.

Vitam Horm. 2015;99:63-90. doi: 10.1016/bs.vh.2015.06.004. Epub 2015 Jul 15. Review.

PMID:
26279373
3.

Stem cell fate decisions: the role of heparan sulfate in the control of autocrine and paracrine signals.

Grünert M, Nurcombe V, Cool SM.

Curr Stem Cell Res Ther. 2008 Jan;3(1):1-8. Review.

PMID:
18220917
4.

Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.

Carreira AC, Zambuzzi WF, Rossi MC, Astorino Filho R, Sogayar MC, Granjeiro JM.

Vitam Horm. 2015;99:293-322. doi: 10.1016/bs.vh.2015.06.002. Epub 2015 Jul 15. Review.

PMID:
26279381
5.

Roles of bone morphogenetic protein signaling in osteosarcoma.

Nguyen A, Scott MA, Dry SM, James AW.

Int Orthop. 2014 Nov;38(11):2313-22. doi: 10.1007/s00264-014-2512-x. Epub 2014 Sep 11. Review.

PMID:
25209345
6.

Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.

Billings PC, Pacifici M.

Connect Tissue Res. 2015;56(4):272-80. doi: 10.3109/03008207.2015.1045066. Review.

7.

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia.

Poli M, Asperti M, Ruzzenenti P, Naggi A, Arosio P.

Molecules. 2017 Apr 8;22(4). pii: E598. doi: 10.3390/molecules22040598. Review.

8.

Bone morphogenetic proteins and their receptor signaling in prostate cancer.

Ye L, Lewis-Russell JM, Kyanaston HG, Jiang WG.

Histol Histopathol. 2007 Oct;22(10):1129-47. doi: 10.14670/HH-22.1129. Review.

PMID:
17616940
9.

The extracellular regulation of bone morphogenetic protein signaling.

Umulis D, O'Connor MB, Blair SS.

Development. 2009 Nov;136(22):3715-28. doi: 10.1242/dev.031534. Review.

10.

Can heparins stimulate bone cancer stem cells and interfere with tumorigenesis?

Sadaie MR.

Ther Adv Drug Saf. 2011 Dec;2(6):271-82. doi: 10.1177/2042098611419312. Review.

11.

Heparan sulfate signaling in cancer.

Knelson EH, Nee JC, Blobe GC.

Trends Biochem Sci. 2014 Jun;39(6):277-88. doi: 10.1016/j.tibs.2014.03.001. Epub 2014 Apr 19. Review.

12.

Growth factor-heparan sulfate "switches" regulating stages of branching morphogenesis.

Nigam SK, Bush KT.

Pediatr Nephrol. 2014 Apr;29(4):727-35. doi: 10.1007/s00467-013-2725-z. Epub 2014 Feb 2. Review.

PMID:
24488503
13.

Heparin, Heparan Sulphate and the TGF-β Cytokine Superfamily.

Rider CC, Mulloy B.

Molecules. 2017 Apr 29;22(5). pii: E713. doi: 10.3390/molecules22050713. Review.

14.

Extracellular regulation of BMP signaling.

Zakin L, De Robertis EM.

Curr Biol. 2010 Feb 9;20(3):R89-92. doi: 10.1016/j.cub.2009.11.021. Review.

15.

Surgically relevant aspects of stem cell paracrine effects.

Crisostomo PR, Markel TA, Wang Y, Meldrum DR.

Surgery. 2008 May;143(5):577-81. doi: 10.1016/j.surg.2007.10.015. Epub 2008 Jan 30. Review. No abstract available.

16.

The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications.

Ayerst BI, Merry CLR, Day AJ.

Pharmaceuticals (Basel). 2017 Jun 13;10(2). pii: E54. doi: 10.3390/ph10020054. Review.

Supplemental Content

Support Center